GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioretec Ltd (FRA:0TN) » Definitions » LT-Debt-to-Total-Asset

Bioretec (FRA:0TN) LT-Debt-to-Total-Asset : 0.04 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Bioretec LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Bioretec's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.04.

Bioretec's long-term debt to total assets ratio declined from Dec. 2023 (0.06) to Dec. 2024 (0.04). It may suggest that Bioretec is progressively becoming less dependent on debt to grow their business.


Bioretec LT-Debt-to-Total-Asset Historical Data

The historical data trend for Bioretec's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioretec LT-Debt-to-Total-Asset Chart

Bioretec Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial 0.51 - 0.20 0.06 0.04

Bioretec Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.04 0.06 0.06 0.04

Bioretec LT-Debt-to-Total-Asset Calculation

Bioretec's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )/Total Assets (A: Dec. 2024 )
=0.434/11.475
=0.04

Bioretec's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )/Total Assets (Q: Dec. 2024 )
=0.434/11.475
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioretec  (FRA:0TN) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Bioretec LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Bioretec's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioretec Business Description

Traded in Other Exchanges
Address
Yrittajankulma 5, Tampere, FIN, FI-33710
Bioretec Ltd is a medical device company focusing on the development of safe, and reliable bioabsorbable and bioresorbable implants for pediatric and adult orthopedics. The company's products are used world wide and continue to further develop materials and products for high-load-bearing clinical applications. Some of its brands include RemeOs, Activa IM-N, ActivaPi, and ActivaScrew.

Bioretec Headlines

No Headlines